BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle
BioNexus Gene Lab Corp. traded up 1.45% to $2.10 in light action Wednesday, with less than 3,000 shares moving on Nasdaq. Market cap was around $5.1 million. The last posted trade came at 10:10 a.m. EDT, pointing to the stock’s lack of liquidity. Trading picked up during the regular U.S. session after the Memorial Day holiday shut markets Monday. Nasdaq’s standard hours are 9:30 a.m. to 4 p.m. Eastern, and the exchange’s 2026 calendar lists May 25—not May 27—as a market holiday.